Share:
Peer-Reviewed Publication
JACC Adv2024;3(8):101094.August 1, 2024Editorial

The Introduction of AI Into Decentralized Clinical Trials: Preparing for a Paradigm Shift.

Jana M Goldberg1, Nivee P Amin2,3, Krista A Zachariah2, Ami B Bhatt4
1Heartbeat Health, New York, New York, USA.
2NewYork Presbyterian-Weill Cornell Medicine, New York, New York, USA.
3Bristol Myers Squibb, Princeton, New Jersey, USA.
4American College of Cardiology, Washington DC, USA.

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.